SCHEMBL21735869

SCHEMBL21735869

c1ccc(-c2cccc(-c3nc(-n4c5ccccc5c5cc6ccccc6cc54)c4c(n3)oc3ccccc34)c2)cc1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 4/20 0.33
SMN1; SMN2 Q16637 4/20 0.33
LMNA P02545 4/20 0.33
PLA2G2A P14555 2/20 0.32
PLA2G4A P47712 2/20 0.32
TERT O14746 2/20 0.32
CYP1A2 P05177 4/20 0.31
CYP3A4 P08684 3/20 0.31
CYP2D6 P10635 3/20 0.31
TP53 P04637 2/20 0.31
KDM4E B2RXH2 2/20 0.31
MAPK1 P28482 2/20 0.31
MAPT P10636 1/20 0.31
HSD17B10 Q99714 1/20 0.31
ALDH1A1 P00352 3/20 0.31
CYP2C9 P11712 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31
MEN1 O00255 2/20 0.31
KMT2A Q03164 2/20 0.31
PLA2G10 O15496 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20669801 0.95 SMN1; SMN2 (0.33) TSHRSMN1; SMN2LMNACYP1A2KDM4E
SCHEMBL21735860 0.94 TSHR (0.37) TSHRSMN1; SMN2LMNACYP1A2KDM4E
SCHEMBL21736065 0.90 TBK1 (0.34) TSHRSMN1; SMN2LMNAPLA2G2APLA2G4A
SCHEMBL24772668 0.88 CHEK2 (0.37) SMN1; SMN2LMNAKDM4EMAPK1MAPT
SCHEMBL20669988 0.88 HCRTR1 (0.33) SMN1; SMN2LMNAKDM4EMAPK1MAPT
SCHEMBL21735901 0.88 CHEK2 (0.31) SMN1; SMN2LMNAMAPK1HSD17B10ALDH1A1
SCHEMBL21736293 0.88 SMN1; SMN2 (0.38) TSHRSMN1; SMN2LMNACYP1A2KDM4E
SCHEMBL20670060 0.88 SMN1; SMN2 (0.38) TSHRSMN1; SMN2LMNACYP1A2KDM4E
SCHEMBL21735864 0.88 TDP1 (0.32) SMN1; SMN2LMNAHSD17B10ALDH1A1
SCHEMBL21736486 0.87 SMN1; SMN2 (0.32) SMN1; SMN2LMNAMAPK1HSD17B10ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11530225-B2 Compound and organic light-emitting diode comprising same LG CHEM, LTD. (KR) 2022-12-20 US disclosed
US-20200055865-A1 COMPOUND AND ORGANIC LIGHT-EMITTING DIODE COMPRISING SAME LG CHEM, LTD. (KR) 2020-02-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11530225-B2 Compound and organic light-emitting diode comprising same CRY1, CRY2, TRPA1 TSHR 4719/4885SMN1; SMN2 1814/4885LMNA 3949/4885
US-20200055865-A1 COMPOUND AND ORGANIC LIGHT-EMITTING DIODE COMPRISING SAME CRY1, CRY2, TRPA1 TSHR 4719/4885SMN1; SMN2 1814/4885LMNA 3949/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.